Scholarly Works

Net benefit of ticagrelor in patients with chronic...

Journal article

Net benefit of ticagrelor in patients with chronic kidney disease

Abstract

A recent subanalysis of data from the PEGASUS-TIMI 54 trial indicates a favourable balance between the efficacy and safety of ticagrelor in patients with prior myocardial infarction (MI), irrespective of their renal function. These results support the long-term use of ticagrelor in patients with chronic kidney disease and prior MI.

Authors

Chan NC; Bosch J

Journal

Nature Reviews Nephrology, Vol. 12, No. 1, pp. 10–11

Publisher

Springer Nature

Publication Date

January 1, 2016

DOI

10.1038/nrneph.2015.196

ISSN

1759-5061

Associated Experts

Jackie Bosch

Professor, FHSRHB

Noel Chan Wan Kai

Associate Professor, FHSMED

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3202 Clinical sciences

Medical Subject Headings (MeSH)

Humans Renal Insufficiency, Chronic

View published work (Non-McMaster Users)

Contact the Experts team

Get technical help

or

Provide website feedback